Air pollution, smoking and built environment are associated with an increase risk of childhood obesity

June 24, 2020

How do environmental exposures during pregnancy and childhood influence the risk of obesity in children? The Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, and the University of Southern California led the first major study to investigate the associations between many pollutants and environmental factors --77 prenatal and 96 childhood exposures-- and the risk of childhood obesity. The findings show that air pollution, smoking and certain characteristics of the built environment--such as high population density-- may play a role in the development of obesity in children.

To date, several studies have addressed the effect of environmental pollutants, lifestyle factors, and urban environment factors on childhood obesity, but they studied each single exposure separately. The exposome concept has changed the way we investigate how environmental risks affect health. Instead of analysing the possible health consequences of, exposome studies consider many different exposures a person faces altogether. This approach takes into account many elements we are exposed to through our diet, lifestyle and the environment where we live.

The new study, which forms a part of the HELIX project and was published in Environmental Health Perspectives, used data on more than 1,300 children aged 6 to 11 years from birth cohort studies in six European countries: France, Greece, Lithuania, Norway, Spain and the United Kingdom.

The authors used data on body mass index (BMI), waist circumference, skinfold thickness and body fat mass to determine the children's overweight and obesity status. Blood and urine samples from the children and their mothers during pregnancy were also analysed. In total, 77 pregnancy and 96 childhood exposures were assessed, including air pollutants, built environment, green spaces, smoking and chemical pollutants (persistent organic pollutants, heavy metals, phthalates, phenols and pesticides).

ISGlobal researcher Martine Vrijheid, who coordinates the HELIX project and was the first author of the study, commented: "The prevalence of childhood obesity is increasing at alarming rates across the globe and may have increased even more than usual during the COVID-19 lockdown period." The findings of the study, which used data collected before anti-COVID-19 measures were introduced, were in line with global trends: the combined prevalence of overweight and obesity was 29% for the study population as a whole, with higher percentages for the cohorts from Spain (43%) and Greece (37%).

The results showed that exposure to smoking (both maternal smoking during pregnancy and second-hand smoking during childhood), air pollution (PM2.5 and PM10 particulate matter and nitrogen dioxide, indoor and outdoor) as well as certain characteristics of the built environment were associated with a higher childhood BMI. Differences in socio-economic status did not explain these findings.

Associations with chemical pollutants were less consistent, with some chemicals measured in child blood (heavy metals copper and cesium) showing higher BMI, and others (persistent organic pollutants such as PCBs and DDE pesticides) showing lower BMI. This may be explained by the fact that chemicals were measured at the same time as obesity in the children, and obesity status may have influenced chemical blood levels. Longitudinal follow-up of the cohort is needed to establish this.

Obesity and Unwalkable Cities

"The children who live in densely populated areas and go to schools in areas with few services and facilities were more likely to be obese," commented Leda Chatzi, Professor of Preventive Medicine at the University of Southern California and last author of the study. The relationship between obesity and the characteristics of the built environment "is in line with the findings of previous research and could be explained by a lack of opportunities for children to walk or engage in other outdoor physical activities," she adds.

"These findings provide further evidence that modifying environmental exposures early in life can limit the risk of obesity and associated complications," commented Martine Vrijheid. "The implications for public health are important since these results may help to identify obesity-related exposures that could be targeted for prevention and intervention early in life." 

Funding: The study received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 308333 - the HELIX Project and the National Institute of Environmental Health Sciences NIEHS R21ES029681.
-end-


Barcelona Institute for Global Health (ISGlobal)

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.